Friday, November 22, 2024
HomeTagsTislelizumab

Tislelizumab

China NMPA Approves Tislelizumab for Patients with Second-Line Esophageal Squamous Cell Carcinoma

BeiGene, Ltd., a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced...

Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the Company will be presenting updated data from the DisTinGuish...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics